Skip to main content
All lobbying filings

BROWNSTEIN HYATT FARBER SCHRECK, LLP

Lobbying for KYVERNA THERAPEUTICS, INC. · Biopharmaceutical company

 Filing 2nd Quarter - Report
Reporting period
2nd Quarter 2026
Apr 1 - June 30 · Posted Jul 17, 2026
Income
$60,000.00
What the client paid this registrant for the period.
Client based in
California

Official filing document

 Government bodies contacted 4
  • Food & Drug Administration (FDA)
  • Health & Human Services, Dept of (HHS)
  • Office of Management & Budget (OMB)
  • White House Office

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

 Lobbying activity 1
Pharmacy

Outreach regarding cell therapies for autoimmune diseases.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem